What are the functional consequences of neurocognitive deficits in schizophrenia?

The American Journal of Psychiatry
M F Green

Abstract

It has been well established that schizophrenic patients have neurocognitive deficits, but it is not known how these deficits influence the daily lives of patients. The goal of this review was to determine which, if any, neurocognitive deficits restrict the functioning of schizophrenic patients in the outside world. The author reviewed studies that have evaluated neurocognitive measures as predictors and correlates of functional outcome for schizophrenic patients. The review included 1) studies that have prospectively evaluated specific aspects of neurocognition and community (e.g., social and vocational) functioning (six studies), 2) all known studies of neurocognitive correlates of social problem solving (five studies), and 3) all known studies of neurocognitive correlates and predictors of psychosocial skill acquisition (six studies). Despite wide variation among studies in the selection of neurocognitive measures, some consistencies emerged. The most consistent finding was that verbal memory was associated with all types of functional outcome. Vigilance was related to social problem solving and skill acquisition. Card sorting predicted community functioning but not social problem solving. Negative symptoms were associated w...Continue Reading

Citations

Sep 10, 2011·Neural Plasticity·Guillermo Gonzalez-BurgosDavid A Lewis
Feb 11, 2014·Journal of Psychiatric Research·Gagan FervahaGary Remington
Oct 23, 2013·European Journal of Clinical Pharmacology·G DésaméricqP Maison
Oct 15, 2013·Psychiatry Research·Tara A NiendamCameron S Carter
May 28, 2014·Psychiatry Research·Raymond W C AuWai-Kwong Tang
Nov 1, 2013·European Archives of Psychiatry and Clinical Neuroscience·Elsa GilbertMichel Maziade
Oct 15, 2013·Schizophrenia Research·S Kristian HillJeffrey R Bishop
Nov 19, 2013·Biological Psychiatry·Teal S EichEdward E Smith
Oct 22, 2013·Biological Psychiatry·Elçin AkdoganElisabeth Bacon
Oct 29, 2013·Schizophrenia Research·Mai-Anh T VuChandlee C Dickey
Feb 25, 2014·Neuroradiology·Sadhana SinghSubash Khushu
May 13, 2014·Comprehensive Psychiatry·Gagan FervahaGary Remington
Jul 27, 2014·Journal of the American Academy of Child and Adolescent Psychiatry·Randal G Ross
Jun 8, 2014·Trends in Pharmacological Sciences·Jason SmucnyJason R Tregellas
Feb 29, 2008·Social Psychiatry and Psychiatric Epidemiology·Nienke JabbenUNKNOWN UK700 Group
Oct 30, 2012·Journal of Autism and Developmental Disorders·Sophie van RijnHanna Swaab
Jun 15, 2012·Social Psychiatry and Psychiatric Epidemiology·Luyken H StoutenMark van der Gaag
May 11, 2011·Psychopharmacology·Patricia BadoRogério Panizzutti
Dec 3, 2014·Psychiatry Research·Azurii K CollierRuben C Gur
Sep 17, 2010·Psychiatry Research·Madeleine deVilleCarmel Loughland
Aug 15, 2014·Clinical Child and Family Psychology Review·Anil ChackoMatthew Jarrett
Aug 15, 2000·Journal of Affective Disorders·J J DunkinS Rosenberg-Thompson
Jun 5, 2012·Acta Neuropsychiatrica·Triptish BhatiaSmita N Deshpande
Sep 17, 2013·Cognitive, Affective & Behavioral Neuroscience·Julia M SheffieldDeanna M Barch
Nov 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·H Y MeltzerR Kessler
May 23, 2001·Journal of Urban Health : Bulletin of the New York Academy of Medicine·P Y CollinsE S Susser
Jul 4, 2003·The Journal of Clinical Investigation·Tonmoy Sharma
Dec 8, 2004·Journal of Psychopharmacology·Kristi A SaccoTony P George
Jun 22, 2005·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·David M GardnerPaul Waraich
Oct 14, 2005·Schizophrenia Bulletin·Philip D HarveyChristopher R Bowie
Feb 17, 2006·Schizophrenia Bulletin·Brian KirkpatrickStephen R Marder
Feb 21, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Gerard Marek, Kalpana Merchant
Apr 28, 2006·Schizophrenia Bulletin·Dawn I VelliganJames M Gold
Aug 19, 2006·Schizophrenia Bulletin·Shannon M CoutureDavid L Roberts
Nov 10, 2006·Schizophrenia Bulletin·Manuel MorrensBernard Sabbe
Nov 14, 2006·Schizophrenia Bulletin·Robert W Buchanan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved